-
1
-
-
33746606765
-
-
Ries L.A.G., Harkins D., Krapcho M., et al. (Eds), National Cancer Institute, Bethesda (Md) Accessed November 8, 2006
-
In: Ries L.A.G., Harkins D., Krapcho M., et al. (Eds). SEER Cancer Statistics Review, 1975-2003 (2006), National Cancer Institute, Bethesda (Md). http://seer.cancer.gov/csr/1975_2003/ Accessed November 8, 2006
-
(2006)
SEER Cancer Statistics Review, 1975-2003
-
-
-
2
-
-
2542520755
-
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)
-
Duensing A., Medeiros F., McConarty B., et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 23 (2004) 3999-4006
-
(2004)
Oncogene
, vol.23
, pp. 3999-4006
-
-
Duensing, A.1
Medeiros, F.2
McConarty, B.3
-
3
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota S., Isozaki K., Moriyama Y., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
4
-
-
0242670019
-
PDGFRA activating mutations in gastrointestinal stromal tumors
-
Heinrich M.C., Corless C.L., Duensing A., et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299 (2003) 708-710
-
(2003)
Science
, vol.299
, pp. 708-710
-
-
Heinrich, M.C.1
Corless, C.L.2
Duensing, A.3
-
5
-
-
0035899418
-
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
-
Tuveson D.A., Willis N.A., Jacks T., et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene 20 (2001) 5054-5058
-
(2001)
Oncogene
, vol.20
, pp. 5054-5058
-
-
Tuveson, D.A.1
Willis, N.A.2
Jacks, T.3
-
6
-
-
20844433223
-
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial
-
Verweij J., Casali P.G., Zalcberg J., et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial. Lancet 364 (2004) 1127-1134
-
(2004)
Lancet
, vol.364
, pp. 1127-1134
-
-
Verweij, J.1
Casali, P.G.2
Zalcberg, J.3
-
7
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
-
(2002)
N Engl J Med
, vol.347
, pp. 472-480
-
-
Demetri, G.D.1
von Mehren, M.2
Blanke, C.D.3
-
8
-
-
34547885048
-
High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors
-
Holden J.A., Willmore-Payne C., Coppola D., Garrett C.R., and Layfield L.J. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors. Am J Clin Pathol 128 (2007) 230-238
-
(2007)
Am J Clin Pathol
, vol.128
, pp. 230-238
-
-
Holden, J.A.1
Willmore-Payne, C.2
Coppola, D.3
Garrett, C.R.4
Layfield, L.J.5
-
9
-
-
4644318371
-
Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas
-
Fine S.W., McClain S.A., and Li M. Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas. Am J Clin Pathol 122 (2004) 552-559
-
(2004)
Am J Clin Pathol
, vol.122
, pp. 552-559
-
-
Fine, S.W.1
McClain, S.A.2
Li, M.3
-
10
-
-
0032950650
-
Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
-
Sakurai S., Fukasawa T., Chong J.M., Tanaka A., and Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol 154 (1999) 23-28
-
(1999)
Am J Pathol
, vol.154
, pp. 23-28
-
-
Sakurai, S.1
Fukasawa, T.2
Chong, J.M.3
Tanaka, A.4
Fukayama, M.5
-
11
-
-
0036303804
-
Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations
-
Heinrich M.C., Rubin B.P., Longley B.J., and Fletcher J.A. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33 (2002) 484-495
-
(2002)
Hum Pathol
, vol.33
, pp. 484-495
-
-
Heinrich, M.C.1
Rubin, B.P.2
Longley, B.J.3
Fletcher, J.A.4
-
13
-
-
0029975817
-
Gastrointestinal stromal tumors
-
Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 13 (1996) 297-313
-
(1996)
Semin Diagn Pathol
, vol.13
, pp. 297-313
-
-
Suster, S.1
-
14
-
-
34147103980
-
The role of KIT in the management of patients with gastrointestinal stromal tumors
-
Hornick J.L., and Fletcher C.D. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 38 (2007) 679-687
-
(2007)
Hum Pathol
, vol.38
, pp. 679-687
-
-
Hornick, J.L.1
Fletcher, C.D.2
-
15
-
-
23944476156
-
PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib
-
Corless C.L., Schroeder A., Griffith D., et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23 (2005) 5357-5367
-
(2005)
J Clin Oncol
, vol.23
, pp. 5357-5367
-
-
Corless, C.L.1
Schroeder, A.2
Griffith, D.3
|